Development of medicinal products for the treatment of alcohol dependence - Scientific guideline
HumanScientific guidelines
On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.
This document provides guidance on the definition of treatment goals, study design, outcome measures, and data analysis for new medicinal products that will be developed to treat alcohol dependence.
Keywords: Alcohol dependence
Current effective version
Related content
- Clinical efficacy and safety: nervous system
- Directive 2001/83/EC
Guideline on the exposure to medicinal products during pregnancy: Need for post-authorisation data- Adjustment for baseline covariates in clinical trials
- ICH E1 Population exposure: the extent of population exposure to assess clinical safety
- ICH E4 Dose response information to support drug registration
- ICH E9 statistical principles for clinical trials
- ICH E10 Choice of control group in clinical trials
- ICH E11(R1) step 5 guideline on clinical investigation of medicinal products in the pediatric population - Scientific guideline
- Investigation of drug interactions
- Missing data in confirmatory clinical trials
- Non-clinical investigation of the dependence potential of medicinal products
- Pharmacokinetic studies in man